Frederic Dolle

Title: The Innovations of Frederic Dolle

Introduction

Frederic Dolle is a notable inventor based in France. He has made significant contributions to the field of biomarker research, particularly in relation to peripheral benzodiazepine receptors. His work has implications for both normal and pathological conditions, showcasing the importance of innovative approaches in medical diagnostics.

Latest Patents

Frederic Dolle holds a patent titled "Use Of 7-Chloro-N,n,5-Trimethyl-4-Oxo-3-Phenyl-3,5-Dihydro-4h-Pyridazino[4,5-B]indole-1-Acetamide As A Biomarker Of Peripheral Benzodiazepine Receptor Levels." This patent focuses on the use of a radiolabelled form of the compound as a biomarker for detecting PBR levels in individuals. The method outlined in the patent is crucial for diagnosing conditions associated with these receptor levels.

Career Highlights

Throughout his career, Frederic Dolle has worked with prominent companies such as Sanofi-Aventis and the Commissariat à l'énergie atomique et aux énergies alternatives (CEA). His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of medical research.

Collaborations

Frederic Dolle has collaborated with notable colleagues, including Jesus Benavides and Herve Boutin. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Frederic Dolle's work exemplifies the impact of innovation in the medical field, particularly through his research on biomarkers and receptor levels. His contributions continue to influence diagnostic methods and enhance our understanding of various health conditions.